October 21, 2019
The Central Social Insurance Medical Council, better known as Chuikyo, approved on October 18 insurance coverage for Chugai Pharmaceutical’s comprehensive genomic profiling test FoundationOne CDx Cancer Genomic Profile as a companion diagnostic to the ROS1/TRK inhibitor Rozlytrek (entrectinib) for the...read more